Evaluating risks and management strategies in heart failure patients
Risk Evaluation and Management in Heart Failure
Ruijin Hospital · NCT02998788
This study looks at how different lifestyle choices and health conditions affect the long-term health of heart failure patients in China over five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ruijin Hospital (other) |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT02998788 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on a population of heart failure patients in China to investigate how various cardiovascular disease risk factors, including lifestyle behaviors, biomarkers, and intermediate diseases, affect heart failure prognosis. The study aims to enroll 1,000 participants who will be followed for at least 5 years to assess the impact of these factors on health outcomes such as all-cause mortality and cardiovascular events. Data will be collected through direct contact with participants, medical records, and vital statistics. The study will utilize the Cox proportional hazard model to analyze the risk factors associated with health outcomes in heart failure patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and above who are hospitalized with specific heart failure conditions and have impaired cardiac function.
Not a fit: Patients with severe co-morbidities that significantly reduce life expectancy or those who refuse to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and health outcomes for heart failure patients through targeted interventions based on identified risk factors.
How similar studies have performed: Other studies have shown success in evaluating risk factors in heart failure, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 18 and above * inpatient with one of the following clinical situations: * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema) * cardiogenic shock * Insufficient high output cardiac * with impaired cardiac function diagnosed by echocardiography * able to provide informed consent Exclusion Criteria: * expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
Where this trial is running
Shanghai, Shanghai Municipality
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine — Shanghai, Shanghai Municipality, China (RECRUITING)
Study contacts
- Principal investigator: Wei Jin, Professor — Ruijin Hospital
- Study coordinator: Zhijun Wu, MD
- Email: totito19822005@126.com
- Phone: 008613818908053
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, Risk Factor, Cardiovascular, heart failure, risk factor, cardiovascular disease, lifestyle behavior